Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 133

1.

Detection of alloantibody-mediated complement activation: A diagnostic advance in monitoring kidney transplant rejection?

Böhmig GA, Kikic Z, Wahrmann M, Eskandary F, Aliabadi AZ, Zlabinger GJ, Regele H, Feucht HE.

Clin Biochem. 2016 Mar;49(4-5):394-403. doi: 10.1016/j.clinbiochem.2015.05.024. Epub 2015 Jun 26. Review.

PMID:
26118475
2.

Evolution of adefovir-resistant HBV polymerase gene variants after switching to tenofovir disoproxil fumarate monotherapy.

van Bömmel F, Trojan J, Deterding K, Wedemeyer H, Wasmuth HE, Hüppe D, Möller B, Bock FJ, Feucht HH, Berg T.

Antivir Ther. 2012;17(6):1049-58. doi: 10.3851/IMP2307. Epub 2012 Aug 14.

PMID:
22892524
3.

Long-term efficacy of tenofovir monotherapy for hepatitis B virus-monoinfected patients after failure of nucleoside/nucleotide analogues.

van Bömmel F, de Man RA, Wedemeyer H, Deterding K, Petersen J, Buggisch P, Erhardt A, Hüppe D, Stein K, Trojan J, Sarrazin C, Böcher WO, Spengler U, Wasmuth HE, Reinders JG, Möller B, Rhode P, Feucht HH, Wiedenmann B, Berg T.

Hepatology. 2010 Jan;51(1):73-80. doi: 10.1002/hep.23246.

PMID:
19998272
4.

[Laryngeal squamous cell carcinoma in a 12-year-old boy].

Muenscher A, Feucht HH, Kutta H, Tesche S, Wenzel S.

HNO. 2009 Jun;57(6):617-20. doi: 10.1007/s00106-008-1817-8. German.

PMID:
19455289
5.

Integration of human papilloma virus type 26 in laryngeal cancer of a child.

Muenscher A, Feucht HH, Kutta H, Tesche S, Wenzel S.

Auris Nasus Larynx. 2009 Apr;36(2):232-4. doi: 10.1016/j.anl.2008.05.011. Epub 2008 Jul 14.

PMID:
18621496
6.

Aymptomatic CMV viremia is associated with increased levels of serum amyloid A in patients with advanced HIV-infection.

Steininger C, Graninger W, Zoufaly A, Zöllner B, Feucht HH, Kundi M, Stahmer I, Stellbrink HJ, van Lunzen J.

Eur J Med Res. 2008 Jun 24;13(6):304-8.

PMID:
18558558
7.

Biotypes of group A streptococci from patients with pharyngitis and soft tissue infections.

Opavski N, Mijac V, Cirković I, Feucht HH, Ranin L.

Clin Microbiol Infect. 2007 Mar;13(3):320-2.

8.

Tenofovir for patients with lamivudine-resistant hepatitis B virus (HBV) infection and high HBV DNA level during adefovir therapy.

van Bömmel F, Zöllner B, Sarrazin C, Spengler U, Hüppe D, Möller B, Feucht HH, Wiedenmann B, Berg T.

Hepatology. 2006 Aug;44(2):318-25.

PMID:
16871563
9.

Clinical reactivation after liver transplantation with an unusual minor strain of hepatitis B virus in an occult carrier.

Zöllner B, Feucht HH, Sterneck M, Schäfer H, Rogiers X, Fischer L.

Liver Transpl. 2006 Aug;12(8):1283-9.

10.

[The discovery of capillary Cd4 in kidney transplantation and the "renaissance" of humoral rejection].

Feucht HE.

Wien Klin Wochenschr. 2006 Jul;118(13-14):426-34. Review. German. No abstract available.

PMID:
16865649
11.

Automated detection and quantitation of bacterial RNA by using electrical microarrays.

Elsholz B, Wörl R, Blohm L, Albers J, Feucht H, Grunwald T, Jürgen B, Schweder T, Hintsche R.

Anal Chem. 2006 Jul 15;78(14):4794-802.

PMID:
16841897
12.

Significance of donor-specific antibodies in acute rejection.

Feucht HE.

Transplant Proc. 2005 Nov;37(9):3693-4.

PMID:
16386508
13.

Diagnostic value of C4d in renal biopsies.

Feucht HE, Mihatsch MJ.

Curr Opin Nephrol Hypertens. 2005 Nov;14(6):592-8. Review.

PMID:
16205481
14.

Prolonged time until seroconversion among hemodialysis patients: the need for HCV PCR.

Schroeter M, Zoellner B, Polywka S, Laufs R, Feucht HH.

Intervirology. 2005;48(4):213-5.

PMID:
15920344
15.
16.

Fatal influenza A infection with Staphylococcus aureus superinfection in a 49-year-old woman presenting as sudden death.

Tsokos M, Zöllner B, Feucht HH.

Int J Legal Med. 2005 Jan;119(1):40-3. Epub 2004 Aug 19.

PMID:
15322829
17.

Changes in the prevalence of hepatitis C virus genotype among injection drug users: a highly dynamic process.

Schroter M, Zollner B, Laufs R, Feucht HH.

J Infect Dis. 2004 Sep 15;190(6):1199-200; author reply 1200-1. No abstract available.

PMID:
15319872
18.

Plasmapheresis in C4d-positive acute humoral rejection following kidney transplantation: a review of 4 cases.

Lennertz A, Fertmann J, Thomae R, Illner WD, Hillebrand GE, Feucht HE, Land W, Samtleben W, Bosch T.

Ther Apher Dial. 2003 Dec;7(6):529-35.

PMID:
15018239
19.

Viral features of lamivudine resistant hepatitis B genotypes A and D.

Zöllner B, Petersen J, Puchhammer-Stöckl E, Kletzmayr J, Sterneck M, Fischer L, Schröter M, Laufs R, Feucht HH.

Hepatology. 2004 Jan;39(1):42-50.

PMID:
14752821
20.

First results on label-free detection of DNA and protein molecules using a novel integrated sensor technology based on gravimetric detection principles.

Gabl R, Feucht HD, Zeininger H, Eckstein G, Schreiter M, Primig R, Pitzer D, Wersing W.

Biosens Bioelectron. 2004 Jan 15;19(6):615-20.

PMID:
14683645
21.

Multiple infections with different HCV genotypes: prevalence and clinical impact.

Schröter M, Feucht HH, Zöllner B, Schäfer P, Laufs R.

J Clin Virol. 2003 Jul;27(2):200-4.

PMID:
12829042
22.
23.

A novel DNA virus (SEN) among patients on maintenance hemodialysis: prevalence and clinical importance.

Schröter M, Laufs R, Zöllner B, Knödler B, Schäfer P, Feucht HH.

J Clin Virol. 2003 May;27(1):69-73.

PMID:
12727531
24.
25.

[Hepatitis C. Virology, transmission modes, clinical aspects, prevention and therapy].

Laufs R, Polywka S, Feucht HH, Schröter M, Zöllner B, Oehler G.

Anaesthesist. 2002 Nov;51(11):884-9. Review. German.

PMID:
12434261
26.

Prevalence of SENV-H viraemia among healthy subjects and individuals at risk for parenterally transmitted diseases in Germany.

Schröter M, Laufs R, Zöllner B, Knödler B, Schäfer P, Sterneck M, Fischer L, Feucht HH.

J Viral Hepat. 2002 Nov;9(6):455-9.

PMID:
12431209
27.

SENV-H viremia and liver transplantation: significant increase of the prevalence.

Schröter M, Laufs R, Sterneck M, Fischer L, Knödler B, Schäfer P, Zöllenr B, Feucht HH.

Blood. 2002 Aug 15;100(4):1518-9. No abstract available.

PMID:
12184282
28.

Genotyping of hepatitis C virus types 1, 2, 3, and 4 by a one-step LightCycler method using three different pairs of hybridization probes.

Schröter M, Zöllner B, Schäfer P, Landt O, Lass U, Laufs R, Feucht HH.

J Clin Microbiol. 2002 Jun;40(6):2046-50.

29.

Epidemiological dynamics of hepatitis C virus among 747 German individuals: new subtypes on the advance.

Schröter M, Zöllner B, Schäfer P, Reimer A, Müller M, Laufs R, Feucht HH.

J Clin Microbiol. 2002 May;40(5):1866-8.

30.

Subtype-dependent response of hepatitis B virus during the early phase of lamivudine treatment.

Zöllner B, Petersen J, Schäfer P, Schröter M, Laufs R, Sterneck M, Feucht HH.

Clin Infect Dis. 2002 May 1;34(9):1273-7. Epub 2002 Apr 2.

PMID:
11941556
31.

Correlation of hepatitis B virus load with loss of e antigen and emerging drug-resistant variants during lamivudine therapy.

Zöllner B, Schäfer P, Feucht HH, Schröter M, Petersen J, Laufs R.

J Med Virol. 2001 Dec;65(4):659-63.

PMID:
11745928
32.

Reappearance of HIV multidrug-resistance in plasma and circulating lymphocytes after reintroduction of antiretroviral therapy.

Albrecht D, Zöllner B, Feucht HH, Lorenzen T, Laufs R, Stoehr A, Plettenberg A.

J Clin Virol. 2002 Feb;24(1-2):93-8.

PMID:
11744433
33.

Comparison of three HCV genotyping assays: a serological method as a reliable and inexpensive alternative to PCR based assays.

Schröter M, Zöllner B, Schäfer P, Laufs R, Feucht HH.

J Clin Virol. 2001 Dec;23(1-2):57-63.

PMID:
11595584
34.

Strategies for reliable diagnosis of hepatitis C infection: the need for a serological confirmatory assay.

Schröter M, Schäfer P, Zöllner B, Polywka S, Laufs R, Feucht HH.

J Med Virol. 2001 Jul;64(3):320-4.

PMID:
11424121
35.

Primary genotypic resistance of HIV-1 to the fusion inhibitor T-20 in long-term infected patients.

Zöllner B, Feucht HH, Schröter M, Schäfer P, Plettenberg A, Stoehr A, Laufs R.

AIDS. 2001 May 4;15(7):935-6. No abstract available.

PMID:
11399967
36.

20-fold increase in risk of lamivudine resistance in hepatitis B virus subtype adw.

Zöllner B, Petersen J, Schröter M, Laufs R, Schoder V, Feucht HH.

Lancet. 2001 Mar 24;357(9260):934-5.

PMID:
11289355
37.

Relevance of reactivity in commercially available hepatitis C virus antibody assays.

Polywka S, Schröter M, Feucht HH, Zöllner B, Laufs R.

J Clin Microbiol. 2001 Apr;39(4):1665-8.

38.
39.

Application of HIV-1 genotypic-resistance testing prevents the evolution of further resistance mutations in heavily pretreated patients.

Zöllner B, Feucht HH, Weitner L, Adam A, Schröter M, Schäfer P, Laufs R.

J Clin Virol. 2001 Apr;21(1):37-45.

PMID:
11255096
40.

Prevalence of a novel DNA virus (TTV) among patients on maintenance hemodialysis.

Schröter M, Feucht HH, Zöllner B, Schäfer P, Laufs R.

Nephron. 2001 Feb;87(2):139-42.

PMID:
11244308
41.

Quantitative detection of hepatitis C virus RNA by light cycler PCR and comparison with two different PCR assays.

Schröter M, Zöllner B, Schäfer P, Laufs R, Feucht HH.

J Clin Microbiol. 2001 Feb;39(2):765-8.

42.

Impact of humoral alloreactivity early after transplantation on the long-term survival of renal allografts.

Lederer SR, Kluth-Pepper B, Schneeberger H, Albert E, Land W, Feucht HE.

Kidney Int. 2001 Jan;59(1):334-41.

43.

Nosocomial outbreak of vancomycin-resistant Enterococcus faecium at a German university pediatric hospital.

Elsner HA, Sobottka I, Feucht HH, Harps E, Haun C, Mack D, Ganschow R, Laufs R, Kaulfers PM.

Int J Hyg Environ Health. 2000 Oct;203(2):147-52.

PMID:
11109567
44.

Gastric outlet obstruction and pulmonary infiltrate in a patient with Crohn's disease: successful treatment by Billroth-II-resection.

Voderholzer WA, Zietz C, Feucht HE, Heldwein W, Hallfeldt H, Huber RM, Loeschke K.

Z Gastroenterol. 2000 Aug;38(8):637-41.

PMID:
11031788
45.

In vivo dynamics and pathogenicity of wild-type and resistant Hepatitis B virus during long-term lamivudine monotherapy - a clinical note.

Zöllner B, Stoehr A, Plettenberg A, Feucht H, Schröter M, Schäfer P, Laufs R.

J Clin Virol. 2000 Sep 1;17(3):183-8.

PMID:
10996115
46.

Identification of three essential regulatory gene loci governing expression of Staphylococcus epidermidis polysaccharide intercellular adhesin and biofilm formation.

Mack D, Rohde H, Dobinsky S, Riedewald J, Nedelmann M, Knobloch JK, Elsner HA, Feucht HH.

Infect Immun. 2000 Jul;68(7):3799-807.

47.

Rapid clearance of human immunodeficiency virus type 1 from ventricular cerebrospinal fluid during antiretroviral treatment.

Eggers C, Stuerenburg HJ, Schafft T, Zöllner B, Feucht HH, Stellbrink HJ, van Lunzen J.

Ann Neurol. 2000 Jun;47(6):816-9.

PMID:
10852550
48.

In vitro susceptibilities of enterococcal blood culture isolates from the Hamburg area to ten antibiotics.

Elsner HA, Sobottka I, Feucht HH, Claussen M, Kaulfers PM, Laufs R, Mack D.

Chemotherapy. 2000 Mar-Apr;46(2):104-10.

PMID:
10671760
49.

Detection of TT virus DNA and GB virus type C/Hepatitis G virus RNA in serum and breast milk: determination of mother-to-child transmission.

Schröter M, Polywka S, Zöllner B, Schäfer P, Laufs R, Feucht HH.

J Clin Microbiol. 2000 Feb;38(2):745-7.

50.

Supplemental Content

Loading ...
Support Center